Spyre Therapeutics Inc.
SYRE | NASDAQ
$90.20
-$1.83 (-1.99%)
Sep 22, 2026, 9:30 AM ET · Market open
Institutional Ownership
Net InflowTotal Institutions
201
Total Ownership
105.26%
Capital Flow
+$1.51B
Shares Change
+1.7M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
58
Increased Positions
123
Reduced Positions
51
Closed Positions
13
New (58)
Increased (123)
Reduced (51)
Closed (13)
Options Sentiment & Activity
bullishPut/Call Ratio
0.088
Call Flow
324,200
Put Flow
28,400
Calls (92%)
Puts (8%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Tudor Investment Corp ET AL | < 0.01% -68.38% | < 0.01% | 2.65K | 243.42K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| FMR LLC | 15.00% +345.93% | 0.03% +61.01% | 11.78M +1.22% | 594.23M +55.85% | |
| Blackrock, Inc. | 7.03% +340.48% | < 0.01% +59.13% | 5.52M -0.02% | 278.49M +53.94% | |
| Rtw Investments, LP | 5.31% +340.55% | 2.09% +52.95% | 4.17M 0.00% | 210.44M +53.97% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove SYRE